NCT02373176View on ClinicalTrials.gov

[14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

[14C]PRC 4016 (Icosabutate)

Single oral dose

Trial Locations (1)

LS2 9LH

Covance Clinical research Unit (CRU) Ltd,Springfield House, Hyde street, Leeds

Sponsors

Lead Sponsor

Pronova BioPharma

All Listed Sponsors

lead

Pronova BioPharma

INDUSTRY